Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Musclepower Enterprise Ltd. dba MONSTER KING and GE LABS
WARNING LETTER
•Musclepower Enterprise Ltd. dba MONSTER KING and GE LABS•November 30, 2025

Musclepower Enterprise Ltd. dba MONSTER KING and GE LABS – FDA Warning Letter, Nov 30, 2025

Record Details

The U.S. Food and Drug Administration (FDA) issued a Warning Letter to Musclepower Enterprise Ltd. dba MONSTER KING and GE LABS on December 12, 2025. Between March and November 2025, the FDA reviewed the company"s websites and obtained product samples, identifying significant violations of the Federal Food, Drug, and Cosmetic Act. The primary issues involve the marketing of products, including “GE Labs Ykarine” and “GE Labs MK 677,” as selective androgen receptor modulators (SARMs). The FDA determined these products are unapproved new drugs because they are not generally recognized as safe and effective for their intended uses. Labeling claims, such as "MYOSTATIN INHIBITOR" and "INCREASE MUSCLE MASS," demonstrate their intended use as drugs. Furthermore, "GE Labs Ykarine" was found to be a misbranded drug, as laboratory analysis confirmed it contains undeclared trendione, an anabolic steroid and controlled substance. Both "GE Labs Ykarine" (containing NAC) and "GE Labs MK 677" (containing ibutamoren) were unlawfully marketed as dietary supplements, as their ingredients are excluded from the dietary supplement definition due to prior drug approvals or investigations. The FDA expressed serious safety concerns regarding SARMs and anabolic steroids, citing risks such as liver toxicity, heart attack, and stroke. Musclepower Enterprise Ltd. is required to address these violations promptly and provide a written response detailing corrective actions.

Company
Musclepower Enterprise Ltd. dba MONSTER KING and GE LABS
Inspection date
November 30, 2025
Product type
Drugs
Office
Office of Unapproved Drugs & Labeling Compliance
Person
  • Tina Smith (Director)
View Company Profile

ID · 27290107-9702-4c56-a0a4-5a1dbd44455b

Violation Codes10
FD&C Act 505(a)FD&C Act 301(d)21.U.S.C. 355(a)21 U.S.C. 331(d)FD&C Act 50221 U.S.C. 352FD&C Act 301(a)21.U.S.C. 331(a)FD&C Act 201(ff)(3)(B)(i)21 U.S.C. 321(ff)(3)(B)(i)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Musclepower Enterprise Ltd. dba MONSTER KING and GE LABS
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.